Outcomes in Patients with Obesity and Coronary Artery Disease with and Without Bariatric Surgery.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
Jun 2020
Historique:
pubmed: 23 2 2020
medline: 15 4 2021
entrez: 22 2 2020
Statut: ppublish

Résumé

The clinical benefit of bariatric surgery in patients with severe obesity and established coronary artery disease (CAD) is unclear. We aimed to compare the cardiovascular outcomes of severely obese CAD patients with and without bariatric surgery. Patients with a history of myocardial revascularization documented prior to bariatric surgery were identified from a dedicated database with prospectively collected outcomes. These patients were matched 1 to 1 with CAD patients who had prior revascularization but who did not undergo bariatric surgery. The primary outcomes were death (cardiac and non-cardiac) and major adverse cardio-cerebral events (MACCE), including death, myocardial infarction (MI), stroke, and repeat myocardial revascularization throughout follow-up. After propensity score matching, 116 bariatric patients were matched with 116 control patients. Ninety-eight had a history of coronary artery bypass surgery and 134 had a previous percutaneous coronary intervention. After a median follow-up of 8.9 (6.3-14.2) years, MACCE was significantly lower in the bariatric group (HR 0.65; 95% CI 0.42-1.00; P = 0.049) driven by a significant reduction in non-cardiac mortality (HR 0.49; 95% CI 0.23-1.00; P = 0.049). There was no significant difference in the rates of all-cause death (HR 0.58; 95% CI 0.33-1.01; P = 0.056), cardiovascular death (HR 0.77; 95% CI 0.31-1.85; P = 0.55), MI (HR 1.09; 95% CI 0.47-2.58; P = 0.85), stroke (HR 1.47; 95% CI 0.24-11.2; P = 0.67), and repeat myocardial revascularization (HR 0.56; 95% CI 0.27-1.13; P = 0.11). Although bariatric surgery in obese CAD patients may reduce the composite MACCE endpoint during long-term follow-up, this effect seems unrelated to cardiovascular outcomes.

Identifiants

pubmed: 32080798
doi: 10.1007/s11695-020-04467-7
pii: 10.1007/s11695-020-04467-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2085-2092

Références

Kotseva K, Wood D, De Bacquer D, et al. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016;23(6):636–48. https://doi.org/10.1177/2047487315569401 .
doi: 10.1177/2047487315569401 pubmed: 25687109
Das SR, Alexander KP, Chen AY, et al. Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol. 2011;58(25):2642–50. https://doi.org/10.1016/j.jacc.2011.09.030 .
doi: 10.1016/j.jacc.2011.09.030 pubmed: 22152950 pmcid: 3523323
Madala MC, Franklin BA, Chen AY, et al. Obesity and age of first non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2008;52(12):979–85. https://doi.org/10.1016/j.jacc.2008.04.067 .
doi: 10.1016/j.jacc.2008.04.067 pubmed: 18786477
Douketis JD, Macie C, Thabane L, et al. Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice. Int J Obes. 2005;29(10):1153–67. https://doi.org/10.1038/sj.ijo.0802982 .
doi: 10.1038/sj.ijo.0802982
Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934. https://doi.org/10.1136/bmj.f5934 .
doi: 10.1136/bmj.f5934 pubmed: 24149519 pmcid: 3806364
Piche ME, Auclair A, Harvey J, et al. How to choose and use bariatric surgery in 2015. Can J Cardiol. 2015;31(2):153–66. https://doi.org/10.1016/j.cjca.2014.12.014 .
doi: 10.1016/j.cjca.2014.12.014 pubmed: 25661550
Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52. https://doi.org/10.1056/NEJMoa066254 .
doi: 10.1056/NEJMoa066254 pubmed: 17715408
Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65. https://doi.org/10.1001/jama.2011.1914 .
doi: 10.1001/jama.2011.1914 pubmed: 22215166
Gurm HS, Brennan DM, Booth J, et al. Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox). Am J Cardiol. 2002;90(1):42–5.
doi: 10.1016/S0002-9149(02)02384-6
Johnson AP, Parlow JL, Whitehead M, et al. Body mass index, outcomes, and mortality following cardiac surgery in Ontario, Canada. J Am Heart Assoc. 2015;4(7) https://doi.org/10.1161/JAHA.115.002140 .
Oreopoulos A, Padwal R, Norris CM, et al. Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis. Obesity (Silver Spring). 2008;16(2):442–50. https://doi.org/10.1038/oby.2007.36 .
doi: 10.1038/oby.2007.36
Buschur ME, Smith D, Share D, et al. The burgeoning epidemic of morbid obesity in patients undergoing percutaneous coronary intervention: insight from the Blue Cross Blue Shield of Michigan cardiovascular consortium. J Am Coll Cardiol. 2013;62(8):685–91. https://doi.org/10.1016/j.jacc.2013.06.004 .
doi: 10.1016/j.jacc.2013.06.004 pubmed: 23948512
Payvar S, Kim S, Rao SV, et al. In-hospital outcomes of percutaneous coronary interventions in extremely obese and normal-weight patients: findings from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol. 2013;62(8):692–6. https://doi.org/10.1016/j.jacc.2013.05.058 .
doi: 10.1016/j.jacc.2013.05.058 pubmed: 23948513
Poirier P. The many paradoxes of our modern world: is there really an obesity paradox or is it only a matter of adiposity assessment? Ann Intern Med. 2015;163(11):880–1. https://doi.org/10.7326/M15-2435 .
doi: 10.7326/M15-2435 pubmed: 26551376
Johnson RJ, Johnson BL, Blackhurst DW, et al. Bariatric surgery is associated with a reduced risk of mortality in morbidly obese patients with a history of major cardiovascular events. Am Surg. 2012;78(6):685–92.
doi: 10.1177/000313481207800623
Lopez-Jimenez F, Bhatia S, Collazo-Clavell ML, et al. Safety and efficacy of bariatric surgery in patients with coronary artery disease. Mayo Clin Proc. 2005;80(9):1157–62. https://doi.org/10.4065/80.9.1157 .
doi: 10.4065/80.9.1157 pubmed: 16178495
Pirlet C, Biertho L, Poirier P, et al. Comparison of short and long term cardiovascular outcomes after bariatric surgery in patients with vs without coronary artery disease. Am J Cardiol. 2019; https://doi.org/10.1016/j.amjcard.2019.09.041 .
Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344–51. https://doi.org/10.1161/CIRCULATIONAHA.106.685313 .
doi: 10.1161/CIRCULATIONAHA.106.685313 pubmed: 17470709
Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61. https://doi.org/10.1056/NEJMoa066603 .
doi: 10.1056/NEJMoa066603 pubmed: 17715409
Lansky AJ, Messe SR, Brickman AM, et al. Proposed standardized neurological endpoints for cardiovascular clinical trials: an academic research consortium initiative. J Am Coll Cardiol. 2017;69(6):679–91. https://doi.org/10.1016/j.jacc.2016.11.045 .
doi: 10.1016/j.jacc.2016.11.045 pubmed: 28183511
Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083–107. https://doi.org/10.1002/sim.3697 .
doi: 10.1002/sim.3697 pubmed: 19757444 pmcid: 3472075
Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240(3):416–23. discussion 23–4
doi: 10.1097/01.sla.0000137343.63376.19
Kwok CS, Pradhan A, Khan MA, et al. Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Cardiol. 2014;173(1):20–8. https://doi.org/10.1016/j.ijcard.2014.02.026 .
doi: 10.1016/j.ijcard.2014.02.026 pubmed: 24636546
Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011;253(3):484–7. https://doi.org/10.1097/SLA.0b013e31820d98cb .
doi: 10.1097/SLA.0b013e31820d98cb pubmed: 21245741
Maciejewski ML, Livingston EH, Smith VA, et al. Survival among high-risk patients after bariatric surgery. JAMA. 2011;305(23):2419–26. https://doi.org/10.1001/jama.2011.817 .
doi: 10.1001/jama.2011.817 pubmed: 21666276
Fisher DP, Johnson E, Haneuse S, et al. Association between bariatric surgery and macrovascular disease outcomes in patients with type 2 diabetes and severe obesity. JAMA. 2018;320(15):1570–82. https://doi.org/10.1001/jama.2018.14619 .
doi: 10.1001/jama.2018.14619 pubmed: 30326126 pmcid: 6233803
Perry CD, Hutter MM, Smith DB, et al. Survival and changes in comorbidities after bariatric surgery. Ann Surg. 2008;247(1):21–7. https://doi.org/10.1097/SLA.0b013e318142cb4b .
doi: 10.1097/SLA.0b013e318142cb4b pubmed: 18156918
Shimada YJ, Tsugawa Y, Iso H, et al. Association between bariatric surgery and rate of hospitalisations for stable angina pectoris in obese adults. Heart. 2017;103(13):1009–14. https://doi.org/10.1136/heartjnl-2016-310757 .
doi: 10.1136/heartjnl-2016-310757 pubmed: 28209590

Auteurs

Charles Pirlet (C)

Quebec Heart-Lung Institute, 2725, Chemin Ste Foy, Quebec, Quebec, G1V 4G5, Canada.

Pierre Voisine (P)

Quebec Heart-Lung Institute, 2725, Chemin Ste Foy, Quebec, Quebec, G1V 4G5, Canada.

Paul Poirier (P)

Quebec Heart-Lung Institute, 2725, Chemin Ste Foy, Quebec, Quebec, G1V 4G5, Canada.
Faculty of Pharmacy, Laval University, Quebec, Canada.

Tomas Cieza (T)

Quebec Heart-Lung Institute, 2725, Chemin Ste Foy, Quebec, Quebec, G1V 4G5, Canada.

Zoltan Ruzsa (Z)

Semmelweiss University, Budapest, Hungary.

Rodrigo Bagur (R)

London Health Sciences Centre, London, Ontario, Canada.

François Julien (F)

Quebec Heart-Lung Institute, 2725, Chemin Ste Foy, Quebec, Quebec, G1V 4G5, Canada.

Frédéric-Simon Hould (FS)

Quebec Heart-Lung Institute, 2725, Chemin Ste Foy, Quebec, Quebec, G1V 4G5, Canada.

Laurent Biertho (L)

Quebec Heart-Lung Institute, 2725, Chemin Ste Foy, Quebec, Quebec, G1V 4G5, Canada.

Olivier F Bertrand (OF)

Quebec Heart-Lung Institute, 2725, Chemin Ste Foy, Quebec, Quebec, G1V 4G5, Canada. Olivier.Bertrand@fmed.ulaval.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH